🔴 Hims Hers Health is trading 4.5% down in after-hours trading after a $0.37-per-share loss and margin contraction

Hims Hers Health is trading 4.53% down now at $30.33 after its second-quarter 2026 earnings release, with a $0.37-per-share loss and weaker margins driving the company-specific reaction.

• Revenue was $753.2 million, above expectations; net loss was $86.3 million, with restructuring and acquisition-integration charges.
• Gross margin fell to 64% from 76% a year earlier.
• Management projected third-quarter revenue of $880 million to $900 million and full-year revenue of $3.1 billion to $3.3 billion; profitability concerns remain central.